1. Dolutegravir is associated with greater viral suppression at birth for human immunodeficiency virus (HIV)-positive pregnant patients compared to standard ...
1. Cabotegravir was shown to be superior to TDF-FTC in preventing HIV infection in women. 2. Both drugs were well ...
1. Single-dose liposomal amphotericin B followed by flucytosine and fluconazole was non-inferior in the treatment of cryptococcal meningitis in HIV-positive ...
1. This randomized controlled trial (RCT) detected a serological response in significantly more patients who received high-dose Hepatitis B (Hep ...
1. Targeted versus nontargeted HIV screening in the emergency department resulted in a similar number of new HIV diagnoses, yet ...
1. Dolutegravir-based antiretroviral therapy regimens effectively suppressed maternal viral load during pregnancy, supporting their use to prevent vertical transmission. 2. ...
1. Broadly neutralizing antibody treatment was shown not to prevent overall HIV-1 acquisition compared to placebo. 2. Sub-group analysis demonstrated ...
1. At week 48, there was a similar proportion of participants with plasma HIV-1 RNA ≥ 50 copies per mL ...
1. Clinical characteristics of HIV-infected individuals appear to be similar to that of the general population and as such should ...
Mortality and pulmonary complications in patients undergoing surgery with perioperative SARS-CoV-2 infection: an international cohort study 1. In patients with ...
Over the past 30 years, the transition from print to digital media has contributed to an exponential increase in medical literature. In response, 2 Minute Medicine presents 160+ authoritative, physician-written summaries of the most cited landmark trials in medicine.
